Cardiogenic diabetes

Heart Failure Reviews

Volumn 19, Issue 5, 2014, Pages 595-602

  Guglin, Maya ^a   Villafranca, Arnaldo ^a   Morrison, Anthony ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Diabetes mellitus; Heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; EPLERENONE; FUROSEMIDE; GLUCOSE; METOPROLOL; SPIRONOLACTONE; GLUCOSE BLOOD LEVEL;

DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART FAILURE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; MORBIDITY; PATHOGENESIS; PREVALENCE; REVIEW; RISK FACTOR; CARDIOGENIC SHOCK; COMPLICATION; INCIDENCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HEART FAILURE; HUMANS; INCIDENCE; INSULIN RESISTANCE; RISK FACTORS; SHOCK, CARDIOGENIC;

EID: 84906936393     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-013-9412-9     Document Type: Review

References (45)

1. Massie BM, Shah NB (1997) Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 133:703-712 (Pubitemid 27287220)
2. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB (2004) The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 27:1879-1884 (Pubitemid 38989226)
3. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njolstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. New Engl J Med 364:829-841
4. Smooke S, Horwich TB, Fonarow GC (2005) Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure. Am Heart J 149:168-174 (Pubitemid 40126505)
5. Gustafsson I, Brendorp B, Seibaek M, Burchardt H, Hildebrandt P, Kober L, Torp-Pedersen C (2004) Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 43:771-777 (Pubitemid 38296474)
6. Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the framingham study. Am J Cardiol 34:29-34
7. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR (2000) Association of glycaemia with macro vascular and microvascular complications of type 2 diabetes (ukpds 35): prospective observational study. BMJ 321:405-412 (Pubitemid 30609442)
8. Held C, Gerstein HC, Yusuf S, Zhao F, Hilbrich L, Anderson C, Sleight P, Teo K (2007) Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation 115:1371-1375 (Pubitemid 46648372)
9. Nichols GA, Moler EJ (2011) Cardiovascular disease, heart failure, chronic kidney disease and depression independently increase the risk of incident diabetes. Diabetology 54:523-526
10. Uriel N, Naka Y, Colombo PC, Farr M, Pak SW, Cotarlan V, Albu JB, Gallagher D, Mancini D, Ginsberg HN, Jorde UP (2011) Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices. Eur J Heart Fail 13:195-199
11. Solang L, Malmberg K, Ryden L (1999) Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J 20:789-795 (Pubitemid 29240249)
12. Amato L, Paolisso G, Cacciatore F, Ferrara N, Ferrara P, Canonico S, Varricchio M, Rengo F (1997) Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The osservatorio geriatrico regione campania group. Diabetes Metab 23:213-218 (Pubitemid 27288299)
13. Bobbio M, Ferrua S, Opasich C, Porcu M, Lucci D, Scherillo M, Tavazzi L, Maggioni AP (2003) Survival and hospitalization in heart failure patients with or without diabetes treated with betablockers. J Card Fail 9:192-202 (Pubitemid 36734316)
14. Suskin N, McKelvie RS, Burns RJ, Latini R, Pericak D, Probstfield J, Rouleau JL, Sigouin C, Solymoss CB, Tsuyuki R, White M, Yusuf S (2000) Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 21:1368-1375 (Pubitemid 30599132)
15. Vermes E, Ducharme A, Bourassa MG, Lessard M, White M, Tardif JC (2003) Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the studies of left ventricular dysfunction (solvd). Circulation 107:1291-1296 (Pubitemid 36314413)
16. Andersson B, Waagstein F (1993) Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J 126:632-640 (Pubitemid 23274296)
17. From AM, Leibson CL, Bursi F, Redfield MM, Weston SA, Jacobsen SJ, Rodeheffer RJ, Roger VL (2006) Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med 119:591-599 (Pubitemid 44041273)
18. Romero SP, Garcia-Egido A, Escobar MA, Andrey JL, Corzo R, Perez V, Garcia-Domiguez GJ, Gomez F (2012) Impact of newonset diabetes mellitus and glycemic control on the prognosis of heart failure patients: a propensity-matched study in the community. Int J Cardiol
19. Gerstein HC, Swedberg K, Carlsson J, McMurray JJ, Michelson EL, Olofsson B, Pfeffer MA, Yusuf S (2008) The hemoglobin a1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (charm) program. Arch Intern Med 168:1699-1704
20. Issa VS, Amaral AF, Cruz FD, Ayub-Ferreira SM, Guimaraes GV, Chizzola PR, Souza GE, Bocchi EA (2010) Glycemia and prognosis of patients with chronic heart failure-sub analysis of the long-term prospective randomized controlled study using repetitive education at 6-month intervals and monitoring for adherence in heart failure outpatients (remade) trial. Am Heart J 159:90-97
21. Eshaghian S, Horwich TB, Fonarow GC (2006) An unexpected inverse relationship between hba1c levels and mortality in patients with diabetes and advanced systolic heart failure. Am Heart J 151:91
22. Tomova GS, Nimbal V, Horwich TB (2012) Relation between hemoglobin a(1c) and outcomes in heart failure patients with and without diabetes mellitus. Am J Cardiol 109:1767-1773
23. Aguilar D, Bozkurt B, Ramasubbu K, Deswal A (2009) Relationship of hemoglobin a1c and mortality in heart failure patients with diabetes. J Am Coll Cardiol 54:422-428
24. Andersson C, Norgaard ML, Hansen PR, Fosbol EL, Schmiegelow M, Weeke P, Olesen JB, Raunso J, Jorgensen CH, Vaag A, Kober L, Torp-Pedersen C, Gislason GH (2010) Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study. Eur J Heart Fail 12:1333-1338
25. Yusuf S, Ostergren JB, Gerstein HC, Pfeffer MA, Swedberg K, Granger CB, Olofsson B, Probstfield J, McMurray JV (2005) Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure. Circulation 112:48-53 (Pubitemid 40962568)
26. Andraws R, Brown DL (2007) Effect of inhibition of the reninangiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials). Am J Cardiol 99:1006-1012 (Pubitemid 46483294)
27. Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR (2006) Effect of ramipril on the incidence of diabetes. New Engl J Med 355:1551-1562 (Pubitemid 44550032)
28. Torp-Pedersen C, Metra M, Charlesworth A, Spark P, Lukas MA, Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Remme WJ, Scherhag A (2007) Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the carvedilol or metoprolol European trial (comet). Heart 93:968-973 (Pubitemid 47122050)
29. Preiss D, van Veldhuisen DJ, Sattar N, Krum H, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B, Zannad F, McMurray JJ (2012) Eplerenone and new-onset diabetes in patients with mild heart failure: results from the eplerenone in mild patient's hospitalization and survival study in heart failure (emphasis-hf). Eur J Heart Fail 14:909-915
30. Newton JD, Squire IB (2006) Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure. Heart 92:1441-1446 (Pubitemid 44578838)
31. Barsheshet A, Garty M, Grossman E, Sandach A, Lewis BS, Gottlieb S, Shotan A, Behar S, Caspi A, Schwartz R, Tenenbaum A, Leor J (2006) Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med 166:1613-1619 (Pubitemid 44232369)
32. Tenenbaum A, Motro M, Fisman EZ, Leor J, Freimark D, Boyko V, Mandelzweig L, Adler Y, Sherer Y, Behar S (2003) Functional class in patients with heart failure is associated with the development of diabetes. Am J Med 114:271-275 (Pubitemid 36398071)
33. Witteles RM, Tang WH, Jamali AH, Chu JW, Reaven GM, Fowler MB(2004) Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link. J Am Coll Cardiol 44:78-81 (Pubitemid 38968461)
34. Egstrup M, Kistorp CN, Schou M, Hofsten DE, Moller JE, Tuxen CD, Gustafsson I (2012) Abnormal glucose metabolism is associated with reduced left ventricular contractile reserve and exercise intolerance in patients with chronic heart failure. Eur Heart J Cardiovasc Imaging
35. Aldasouqi SA, Logue WJ (2000) The batista procedure significantly improved cardiac function and glycemic control in a diabetic patient with severe insulin resistance. Diabetes Care 23:255-256 (Pubitemid 30071035)
36. Wong AK, AlZadjali MA, Choy AM, Lang CC (2008) Insulin resistance: a potential new target for therapy in patients with heart failure. Cardiovasc Ther 26:203-213
37. Ingelsson E, Sundstrom J, Arnlov J, Zethelius B, Lind L (2005) Insulin resistance and risk of congestive heart failure. JAMA 294:334-341 (Pubitemid 41043777)
38. Swan JW, Walton C, Godsland IF, Clark AL, Coats AJ, Oliver MF (1994) Insulin resistance in chronic heart failure. Eur Heart J 15:1528-1532 (Pubitemid 24350611)
39. Paolisso G, De Riu S, Marrazzo G, Verza M, Varricchio M, D'Onofrio F (1991) Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. Metabolism 40:972-977
40. Heck PM, Dutka DP (2009) Insulin resistance and heart failure. Curr Heart Fail Rep 6:89-94
41. Chokshi A, Drosatos K, Cheema FH, Ji R, Khawaja T, Yu S, Kato T, Khan R, Takayama H, Knoll R, Milting H, Chung CS, Jorde U, Naka Y, Mancini DM, Goldberg IJ, Schulze PC (2012) Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure. Circulation 125:2844-2853
42. Nikolaidis LA, Sturzu A, Stolarski C, Elahi D, Shen YT, Shannon RP (2004) The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy. Cardiovasc Res 61:297-306 (Pubitemid 38091770)
43. AlZadjali MA, Godfrey V, Khan F, Choy A, Doney AS, Wong AK, Petrie JR, Struthers AD, Lang CC (2009) Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. J Am Coll Cardiol 53:747-753
44. Doehner W, Rauchhaus M, Ponikowski P, Godsland IF, von Haehling S, Okonko DO, Leyva F, Proudler AJ, Coats AJ, Anker SD (2005) Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol 46:1019-1026 (Pubitemid 41316509)
45. Coats AJ, Anker SD (2000) Insulin resistance in chronic heart failure. J Cardiovasc Pharmacol 35:S9-S14